Ark Biotech has filed a notice of an exempt offering of securities to raise $11,028,749.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Ark Biotech is raising up to $11,028,749.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Yosef Quint played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Ark Biotech
Ark Biotech is a manufacturer of fit-for-purpose, bioreactors and operating systems intended for the industrial production of cultivated meat. Building fit-for-purpose, affordable bioreactors and operating systems for the industrial production of cultivated meat.
To learn more about Ark Biotech, visit http://www.ark-biotech.com/
Contact:
Yosef Quint, Chief Executive Officer
718-757-2398
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.